An illustrative drug delivery system implantable in a recipient may include a connection assembly, a source catheter, and a microcatheter. A proximal end portion of the source catheter may be configured to be fluidically connected to a fluid source configured to provide a fluid (e.g., a neurotherapeutic drug). A distal end portion of the source catheter may be configured to be fluidically connected to the connection assembly. The microcatheter may include a proximal end portion configured to be fluidically connected to the connection assembly and a distal end portion comprising an elution opening configured to elute the fluid to a target location (e.g., a brain) within a recipient. The fluid source may be configured to provide the fluid to the target location by way of the source catheter, the connection assembly, and the microcatheter.

A chest drainage system securing apparatus for securing and maintaining chest drainage systems in position following placement into a human or animal patient and preventing movement or unplanned removal thereof in response to the application of significant forces in any direction thereto, be they longitudinal, torsional/rotational or bending. The securement system includes retention devices secured to a chest tube which interact with an adhesive pad releasably attached to a patient to ensure proper positioning of the chest tube. The adhesive pad includes one or more Heimlich-type valves for sealing sucking chest wounds and for sealing an incision formed in a patients skin and chest for the placement and insertion of a chest tube.

Intravenous cannula devices configured to prevent blood backflow and needle prick injuries include a catheter assembly and a needle guard assembly. The catheter assembly includes a hub having a coaxial recess and a valve member positioned therein. The valve member is cylindrical and includes a distal surface having slits collectively defining prongs configured to open and close upon passage of a needle therethrough. Cannula devices configured to prevent needle stick injuries include a safety release component at a distal end of the needle guard assembly. The safety release component includes moveable locking elements configured to fit within an annular groove defined by a proximal portion of the hub upon movement of a needle through the safety release component. Proximal retraction of the needle through the safety release component causes the moveable locking elements to be displaced from the annular groove, thereby decoupling the catheter assembly from the needle guard assembly.

Disclosed is a catheter device including a proximal tube having a first part of a first lumen; a distal tube having a second part of the first lumen; a second lumen connecting the proximal tube and the distal tube; wherein the connection comprise an area of discontinuity between the first part and second part; wherein the area of discontinuity comprises a support element configured to resist axial movement of the distal tube relative to the proximal tube and vice versa; and wherein the second lumen is arranged to activate or cause at least one obstruction element to restrict the flow of urine from the proximal tube to the area of discontinuity and to restrict the flow of urine from the area of discontinuity to the distal tube.

Described herein is a liquid embolic delivery device designed to minimize excess embolic solvent buildup therein. The liquid embolic delivery device generally comprises an outer catheter, an inner catheter that is longitudinally moveable within the outer catheter. The inner catheter is used for an initial embolic solvent flush and to deliver liquid embolic, while the outer catheter is used to remove excess solvent.

A user-controllable urinary catheter prosthesis (20) is provided for minimally-invasive insertion into a subject. The prosthesis (20) includes a proximal intra-urethral assembly (22), configured to be inserted entirely within a urethra (102) via a meatus (104). A user-activatable hydraulic activator (50) is disposed along a flexible intra-urethral catheter (30, 430), which is shaped so as to define a urinary outlet (40, 440) at a proximal end (41, 441) thereof. A distal bladder assembly (32, 132, 232, 332) is configured to be disposed in a bladder of the subject, and includes a bladder anchor (48). A hydraulic valve (60, 160, 260, 360) is configured to assume an open state, in which urine flow is allowed between the distal bladder assembly (32, 132, 232, 332) and the urinary outlet (40, 440); and a closed resting state, in which urine is entirely blocked from entering the distal bladder assembly (32, 132, 232, 332) and exiting the urinary outlet (40, 440). Application of pressure to the hydraulic activator (50) transitions the hydraulic valve (60, 160, 260, 360) from the closed resting state to the open state. Other embodiments are also described.

A catheter insertion system includes a housing extending along a longitudinal axis. A needle extends distally from a distal end of the housing. The needle has a longitudinal passage coaxially aligned with the housing. A catheter has a length and is sized and shaped to be advanced from a retracted position within the longitudinal passage of the needle to an extended position with at least a portion of the catheter length extending beyond a distal tip of the needle. The needle is typically configured to be retracted back into the housing after the catheter has been advanced, thus providing an integrated catheter and catheter insertion apparatus. After needle retraction, the housing may be taped to the patient's skin while the needle remains protected within the housing. A luer on the catheter may then be connected to a fluid or other source in an otherwise conventional manner.

The invention relates to a device for applying a pharmaceutical fluid, having a tube and a valve element, wherein the tube can be connected in terms of fluid conduction via a first tube end to a reservoir for the pharmaceutical fluid, and wherein the valve element is arranged in a second tube end of the tube. The invention furthermore relates to a system for applying a pharmaceutical fluid, having a reservoir for the pharmaceutical fluid and such a device, and to a method for applying a pharmaceutical fluid by means of such a device.

The wound drainage apparatus for drug-assisted removal of bodily fluids includes a double-lumen tubing member connected to a customizable branched tubing member for placement in a wound cavity. A perforated inner tube connected to an anticoagulant drug delivery pump and a solid outer tube connected to a fluid drainage vacuum make up the double-lumen tubing member. The branched tubing member includes a plurality of secondary wound cavity tubes branching away from a primary wound cavity tube. The apparatus disclosed herein improves upon current drainage systems by preventing occlusions produced by blood clots forming in fluid drainage tubes.

A user-controllable urinary catheter prosthesis (20) is provided for minimally-invasive insertion into a subject. The prosthesis (20) includes a proximal intra-urethral assembly (22), configured to be inserted entirely within a urethra (102) via a meatus (104). A user-activatable hydraulic activator (50) is disposed along a flexible intra-urethral catheter (30, 430), which is shaped so as to define a urinary outlet (40, 440) at a proximal end (41, 441) thereof. A distal bladder assembly (32, 132, 232, 332) is configured to be disposed in a bladder of the subject, and includes a bladder anchor (48). A hydraulic valve (60, 160, 260, 360) is configured to assume an open state, in which urine flow is allowed between the distal bladder assembly (32, 132, 232, 332) and the urinary outlet (40, 440); and a closed resting state, in which urine is entirely blocked from entering the distal bladder assembly (32, 132, 232, 332) and exiting the urinary outlet (40, 440). Application of pressure to the hydraulic activator (50) transitions the hydraulic valve (60, 160, 260, 360) from the closed resting state to the open state. Other embodiments are also described.